Immunitas Therapeutics is based in Waltham, Massachusetts. It has raised $97M in total funding. Latest round: Series B.
Immunitas Therapeutics is based in Waltham, Massachusetts. Immunitas Therapeutics has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Immunitas Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Agent Capital, Evotec, Leaps by Bayer, Novartis Venture Fund. 4 distinct backers are named across the disclosed rounds.
Every Immunitas Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Waltham at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026